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Methylprednisolone Inhibits Pemphigus Acantholysis in Skin Cultures 
DAVID L. SWANSON, M.D. AND MARK V. DAHL, M.D. 
Department of Dermatology, University of Minnesota Medical School, Minneapolis, Minnesota, U.S.A. 
Glucocorticosteroids are used to treat patients with 
pemphigus, but the mechanism of action is unknown. 
We studied the effect of methylprednisolone on acantho-
lysis induced in vitro by incubation of normal skin with 
plasma from a patient with pemphigus. Normal human 
breast skin was maintained in organ cultures for several 
days in Ham F -10 medium. Plasma from a patient with 
active pemphigus vulgaris caused suprabasilar epider-
mal acantholysis when added to this culture system. In 
control cultures (F-10 medium and fetal bovine serum), 
no acantholysis ·occurred. Acantholysis was prevented 
when breast skin was preincubated for 24 h in a 0.25 
mM solution of methylprednisolone in F -10 medium and 
fetal bovine serum, suggesting that methylprednisolone 
directly inhibits acantholysis. No suppression of acan-
tholysis occurred when the methylprenisolone was 
added to the culture system simultaneously with the 
pemphigus plasma, suggesting a time requirement for 
alteration of cellular events. The inhibition of acantho-
lysis was not caused by cell death since methylpredni-
solone did not alter keratinocyte viability as determined 
by exclusion of trypan blue dye when keratinocytes 
were exposed to pemphigus plasma. Similarly, the in-
hibition of acantholysis was not due to dissolution, al-
teration, or coating of pemphigus antigen on epidermal 
cells, since the intercellular antibodies in the plasma 
bound as well to methylprednisolone-treated epidermis 
as to untreated epidermis. 
Pemphigus is a bullous skin disease in which epidermal cells 
lose their attachment to each other. Patients with pemphigus 
have antibodies in their skin and plasma which bind to the 
intercellular areas of epidermis and may be pathogenic [1]. 
These antibodies can induce epidermal acantholysis in vitro by 
a mechanism which requires neither complement nor inflam-
matory cells [2). High doses of systemic corticosteroids may 
prevent the appearance of new bullae in patients with pemphi-
gus [3]. The mechanism by which corticosteroids inhibit acan-
tholysis is unknown. We investigated the effect of methylpred-
nisolone on acantholysis produced by pemphigus antibody in 
vitro. 
METHODS 
Effect of Methylprednisolone on Acantholysis 
Human skin was maintained in skin organ culture by a modification 
of the methods of Sarkany et a! [4]. Acantholysis was induced in 
specimens by the method of Schiltz and Michel [5]. Squares of normal 
human breast skin (4 X 4 X Y.! mm) were placed on sterile lens tissue. 
This tissue paper had waxed edges so that it and the skin specimen 
would float in various test media. Tissue, tissue paper, and media were 
placed in a watch glass and maintained in a sterile, covered cul ture-
dish containing wet gauze to insure high humidity. The system was 
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incubated in a humidifed 4% C02 atmosphere at 37°C. Specimens were 
incubated for 3 days. After incubation, organ culture specimens were 
removed from their paper rafts, fixed in formalin, sectioned, and stained 
with hematoxylin and eosin. Specimens were then coded and examined 
by light microscopy to determine whether acantholysis was present. 
Acantholysis was defined as t he presence of a suprabasilar cleft. Spec-
imens were read blindly by 3 histopathologists to eliminate any possible 
prejudice. 
To study t he effects of methylprednisolone on inhibition of acantho-
lysis, skin specimens were incubated in Ham F-10 medium [6] (1 ml) 
and fetal calf serum (FCS) (1 ml) with methylprednisolone (0.25 mM) 
(Upjohn Co., Kalamazoo, Michigan). Methylprednisolone at a 0.25 mM 
concentration approximates the distribution of 1 g of methylpredniso-
lone in the extracellular fluid of a 60-kg woman. After a va riable 
preincubation period, citrated plasma (1 ml) derived from a patient 
with active pemphigus was added to the medium (Table 1). All experi-
ments were repeated at least 4 times. To induce acantholys is, plasma 
from a patient with active pemphigus with intercellular antibodies at 
1:320 titer was added to the medium either init ia lly or after a 24-h 
preincubation in FCS and Ham F-10 medium. As controls, organ 
culture specimens were incubated in Ham F -10 medium contain ing 
either FCS or normal human plasma either with or without 0.25 % rnM 
methylprednisolone (Table II). 
Effect of Methylprednisolone on Antibody Binding 
Two experiments were performed to study t he effect of methylpred-
nisolone on t he binding of pemphigus antibody to the inte rcellular 
areas of human epidermis. To determine whether methylprednisolone 
absolutely inhibi ted pemphigus ant ibody binding, human skin was 
incubated in organ cultures as described above in medium initially 
containing FCS (1 cc), Ham F-10 medium (1 cc), and 0.25 mM meth-
ylprednisolone. After 24-h preincubation, pemphigus plasma (1 cc) was 
added. Two days later, specimens were removed from medium and 
frozen in liquid nitrogen . Four-micron frozen tissue sections were 
studied for the presence of lgG using a standard direct immunofluores-
cence technique [7]. 
To determine whether methylprednisolone partially inhibited t he 
binding of pemphigus antibody to the in tercellular epidermis, studies 
were conducted to see whether preincubation of skin with methylpred-
nisolone could reduce the apparent t iter of pemphigus antibody when 
the incubated skin was subsequently used as a substrate for indirect 
immunofluorescence. Human skin was incubated in organ cultures as 
described above. Specimens were incubated for 24 h in equal amounts 
of Ham F-10 medium and FCS with or without 0.25 mM methylpred-
nisolone. Following incubation, specimens were frozen, sectioned, 
washed, and incubated for 30 min in serial dilutions of pemphigus 
p lasma with or without 0.25 mM methylprednisolone. Specimens were 
washed in phosphate-buffered saline and incubated with fluorescein-
labeled goat antihuman lgG for 30 min. After washing, specimens were 
examined for fluorescence of the intercellular areas of epidermis. 
Effect of Methylprednisolone on Cell Viability 
Cell viability was determined in explants themselves·. Fresh human 
skin was incubated with and without methylprednisolone and with 
pemphigus or control plasma as described above. After 1-, 2-, or 3-day 
incubation, the epidermis was separated from the dermis by incubation 
in 0.5% t rypsin-EDTA solution for 1 hat 37°C. The epidermal sheet 
was cut into squares and teased apart in a solut ion of DNAase 0.025 %. 
The epidermal sheets were t iturated briskly in and out of a small 
pipette to dislodge keratinocytes. Two parts of suspension were mixed 
with 1 part of 1% trypan blue solution and examined after 5 min for 
the ability of cells to exclude trypan blue dye. 
RESULTS 
Effect of Methylprednisolone on Acantholysis 
Acantholysis was recorded as present if suprabasilar intrae-
pidermal clefting was present in skin specimens. Acantholysis 
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was present after incubation in control solutions containing 
pemphigus plasma (Fig 1). No acantholysis was observed in 
controls uti lizing normal plasma (Table II). Acantholysis was 
a lways absent in skin maintained in medium containing pem-
phigus plasma and methylprednisolone after a 24-h preincu-
bation in methylprednisolone (Fig 2). After a preincubation of 
only 1 or 4 h in methylprednisolone, separation and acantho-
lysis were induced by pemphigus plasma. In these equivocal 
specimens, some separation of cells in the suprabasilar area 
suggested early acantholysis, but free-floating epidermal cells 
were absent. The same equivocal changes were observed each 
time the experiment was repeated using t he short 1- to 4-h 
preincubation. 
TABLE I. Effect of preincubation of skin in methylprednisolone on 
elicitation of acantholysis 
Time of addition of pemphigus plasma (PP) 
to initial medium• 
0 hours 1 hour 4 hours 24 hours (day (day 1) 2) 
PP (1 ml) 
PP (1 ml) 
PP (1 ml) 







• The initial medium consisted of fetal calf serum 1 ml, F-10 medium 
1 ml, methylprednisolone 0.25 mM. 
TABLE II. Control experiments 
Experiment Time of addition of reagents to sk in culture Acantholysis 
no. Oh 24 h 48 h at 72 hours 
1 FCS 1 ml PP 1 ml Present 
F-10 1 ml 
2 FCS 1 ml PP 1 ml Present 
F-10 1 ml 
3 FCS 1 ml NP 1 ml Absent 
F-10 1 ml 
4 FCS 1 ml NP 1 ml Absent 
F-10 1 ml MP 
Schedule of contro l experiments which show that pemphigus plasma 
causes acantholysis but normal plasma and methylprednisolone do not. 
Skin cultures were incubated in fetal calf serum and Ham F -10 medium. 
Pemphigus plasma, normal plasma, or methylprednisolone were added 
24 or 48 h late r. 
FCS = fetal calf serum; F -10 = Ham serum F -10 medium; PP = 
plasma from ·pemphigus patient; NP = plasma from normal cont rol; 
MP =methylprednisolone (40 mg/ ml). 
FIG 1. Photomicrograph of skin showing acant holysis after incu-
bation with media for 24 h and pemphigus plasma for 2 days (original 
magnification X100). 
FIG 2. Photomicrograph of skin showing inhibition of acantholysis 
by methylprednisolone. The skin had been incubated with 0.25 mM 
methylprednisolone for 24 h and with methylprednisolone and pem-
phigus plasma for 2 more days (original magnification X100). 
Effect of Methylprednisolone on Antibody Binding 
Immunofluorescence studies demonstrated that methylpred-
nisolone neither abolished nor inhibited binding of pemphigus 
antibody to t he intercellular epidermis. The pattern of antibody 
binding was typical of that seen in sk in of patients with 
pemphigus vulgaris. When skin and skin sections incubated 
wit h methylprednisolone were used as a substrate for indirect 
immunofluorescence, there was no reduction in the apparent 
titer of intercellular antibody. 
Effect of Methy lprednisolone on. Cell Viability 
After 1 to 3 days in organ culture, the viability of cells 
incubated with pemphigus plasma with or without methylpred-
niso lone was about 10%. The viability of cells incubated wit h 
normal human plasma with or without methylprednisolone was 
about 60%. In other words, methylprednisolone had no effect 
on cell viability, while pemphigus plasma appeared cytotoxic. 
This cytotoxicity occurred during the first 24 h of incubation 
with pemphigus plasma. No additional cytotoxicity was ob-
served after 48- or 72-h incubations. 
CONCLUSIONS 
Pemphigus vulgaris is a chronic bullous skin disease which 
may cause death. Systemic glucocorticosteroids can prevent the 
development of new bullae, and may be life-saving. Large doses 
of systemic corticosteroids as high as 1 g of prednisone daily 
are required [3]. This is much greater than the daily doses of 
corticosteroids necessary to completely suppress inflammation 
in inflammatory disorders such as lupus erythematosus and 
rheumatoid arthritis. This suggests t hat glucocorticoids sup-
press bulla formation by a mechanism unrelated to inflam-
mation. 
Binding of antibody to epidermal cells may induce them to 
secrete a nonlysozomal protease which alters the intercellular 
cement substance to cause epidermal dyshesion [2,8,9]. Such a 
mechanism does not require the participation of complement, 
but does require epidermal cell viability and is therefore con-
sistent with requirements for acant holysis in vitro. We have 
found that methylprednisolone in high concentrations can com-
pletely inhibit acantholysis produced by pemphigus antibody 
in organ culture: Just how methylprednisolone does t his is not 
known. We observed that methylprednisolone does not affect 
antibody binding. We also found no glucocorticoid effect on 
cell viability. A similar absence of toxicity from corticosteroids 
had been made by others using hepatocytes [10] and myocar-
dium [11] in vitro. Perhaps methylprednisolone direct ly inhib-
its synthesis or release of protease by epidermal cells. 
260 SWANSON AND DAHL 
Schiltz and Michel were unable to block in vitro pemphigus 
acantholysis with glucocorticosteroids [9]. We also found no 
inhibition unless the organ culture was preincubated in meth-
ylprednisolone for 4-24 h before addition of pemphigus anti-
bodies. However, with adequate preincubation, acantholysis 
was totally suppressed. Perhaps a 4- to 24-h lag time is required 
for methylprednisolone to diffuse to the epidermal cells, enter 
them, and inhibit metabolic events. In vitro, prednisone may 
also inhibit antibody synthesis although the major decline in 
antibody titers occurs 3-4 weeks after glucocorticoid adminis-
tration [12-14] . 
In order to suppress acantholysis in organ culture, high 
concentrations of methylprednisolone are required ." Complete 
inhibition of acantholysis was observed only when the incuba-
tion medium contained methylprednisolone in a concentration 
of at least 0.25 mM [15] . Although concentrations of this 
magnitude have been approached physiologically during treat-
ment of patients with active pemphigus, this concentration 
requirement is higher than that usually required to control the 
disease. Perhaps a longer preincubation of skin with lower 
concentrations of methylprednisolone would also inhibit acan-
tholysis in tissue culture, but artifacts occur in skin cultures 
after 72 h [2] which make interpretation difficult. Alternatively, 
the events in tissue culture may not absolutely reflect events 
in patients, so concentration requirements may not be directly 
comparable. 
Schiltz et al [2] observed that pemphigus antibody was cy-
totoxic to epidermal cells in culture. The severity of cytotoxicity 
appeared to directly correlate with the titer of antibody. In our 
culture system, pemphigus antibody also caused keratinocytes 
to die. The clinical relevance of this cytotoxicity, if any, is 
uncertain. Methylprednisolone neither caused cell death, nor 
prevented the cytotoxicity of pemphigus plasma. 
Our studies support the concept that acantholysis of pem-
phigus is caused by a binding of antibody to epidermal cells. 
Methylprednisolone in organ culture can block acantholysis. 
The high dose requirements are consistent with the clinical 
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observation that high doses of systemic corticosteroids are 
necessary to successfully stop new blister formation in patients 
with pemphigus. 
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